Authors register: W.M.A. Verhoeven
Case report
2010/11
Toxic plasma concentration of clozapine in inflammatory processes , 791 - 796
Review article
2009/3
An algorithm for psychotropics for the mentally handicapped: psychiatric diagnosis in three stages , 161 - 171
Case report
2008/10
Chemotherapy during clozapine treatment. Increased risk of agranulocytosis?, 673 - 678
Case report
2007/4
Autism and catatonia: successful treatment using lorazepam. A case study , 257 - 261
Case report
2006/10
Psychoses and Epilepsy. A case study , 809 - 814
Letter to the editor
2005/10
Reactie op 'Katatonie, een syndroom om te herinneren'
Letter to the editor
2003/5
Reactie op 'Cycloïde psychose: een vergeten diagnose? Een literatuuronderzoek', 293 - 296
Commentaar
2003/11
Verstandelijk gehandicapten: op weg naar een medisch-specialistische emancipatie, 697 - 700
Short report
2000/4 Themanummer Psychiatrie en Opleiding
Psychiatry and neurosciences, 257 - 263
---
1999/4
Pharmacotherapy in people with learning disabilities; a dimensional approach , 219 - 231
---
1999/3
Neuropsychiatric diagnostic procedures in people with learning disabilities, 151 - 163
New research
1995/5
Assessment of Medical Competence in the psychiatric training program
New research
1987/9
Conceptual and methodological problems around the theme: negative symptoms, 550 - 0
New research
1987/10
Pathophysiological and therapeutical aspects of negative symptoms
New research
1986/9
Neuropeptides and depression
Short report
1984/9
Biologische determinanten van schizofrene psychosen, 665 - 687
Short report
1980/10
Research in biological determinants of schizofrenic psychoses , 618 - 632
Short report
1979/4-11
Neuropeptiden en hun potentiële klinische betekenis, 560 - 582




